Of the pro-tumorigenic pathways, NF-κB stands out as a known target of COX enzymes in ovarian cancer [56] and is an important link between many of the pathways that intersect the COX-1/PG axis in ovarian cancer cells [47, 48]. This evidence concerns the gene NFKB1 and ovarian carcinoma.